Partner Event: R&D Governance, Controlling and Innovation for Pharma
Mon 21 Sept
|Frankfurt am Main
Build the R&D operating model behind faster decisions, sharper resource allocation and stronger pipeline value
Time & Location
21 Sept 2026, 09:00 CEST – 23 Sept 2026, 16:30 CEST
Frankfurt am Main, Frankfurt am Main, Germany
About the event
The Marcus Evans R&D Governance, Controlling and Innovation for Pharma conference taking place on 21-23 September, 2026, in Frankfurt, Germany, will focus on how pharma R&D leaders can redesign decision‑making, governance and operating models to improve development success, portfolio productivity and probability of success under revenue disruption, pricing reform and intensifying regulatory and competitive pressure in Europe. Sessions will explore evidence‑driven kill criteria, portfolio and platform prioritisation, build‑versus‑buy and divestiture choices, and the integration of regulatory, reimbursement and market‑access realities earlier in investment decisions, including how to reflect EU HTA and country‑specific pricing constraints in R&D capital allocation.
Attending This Premier Marcus Evans Conference Will Enable You to:
• Redesign R&D decision-making to stop weak programmes earlier
• Build R&D decision frameworks that trigger real stop/go calls